Differential effector and secretory functions of microglial cell lines derived from BCG-resistant and -susceptible congenic mouse strains

Journal of Neuroimmunology

Volumn 101, Issue 1, 1999, Pages 27-33

  Puliti, Manuela ^a   Mazzolla, Rosanna ^a   Brozzetti, Annalisa ^a   Neglia, Rachele ^b   Radzioch, Danuta ^c   Bistoni, Francesco ^a   Blasi, Elisabetta ^b  

^a Microbiology Section   (Italy)

^b Department of Hygiene   (Italy)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Microglial cells; Mycobacteria: bcg Nramp1 gene

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; CYTOKINE RELEASE; FLOW CYTOMETRY; GENOTYPE; MACROPHAGE; MICROGLIA; MOUSE; MYCOBACTERIUM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CELL LINE; CYTOKINES; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICROGLIA; MYCOBACTERIUM BOVIS; NITRIC OXIDE;

EID: 0032744269     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00127-7     Document Type: Article

References (33)

1. Barrera L.F., Kramnik I., Skamene E., Radzioch D. Nitrate production by macrophages derived from BCG-resistant and susceptible congenic mouse strains in response to IFN-γ and infection with BCG. Immunology. 82:1994;457-464.
2. Barton C.H., Whitehead S., Blackwell J.M. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 3:1995;267-279.
3. Bignami E., Eng L.F., Dahl D., Uyeda C.T. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 43:1972;429-435.
4. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27:1990;229-237.
5. Blasi E., Barluzzi R., Mazzolla R., Tancini B., Saleppico S., Puliti M., Pitzurra L., Bistoni F. Role of nitric oxide and melanogenesis in the accomplishment of the anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:1995;111-116.
6. Colton C.A., Gilbert D.L. Production of superoxide anions by a CSN macrophage, the microglia. FEBS Lett. 223:1987;284-290.
7. Cooper A.N., Roberts A.D., Rhoades E.R., Callahan J.E., Getzy D.M., Orme I.M. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology. 84:1995;423-430.
8. Denis M., Gregg E. Recombinant interleukin 6 increases the intracellular and extracellular growth of Mycobacterium avium. Can. J. Microbiol. 37:1991;479-488.
9. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1988;2407-2411.
10. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;54-57.
11. Flesch I.E.A., Kaufmann S.H.E. Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2 (interleukin 6). Infect. Immun. 58:1990;269-277.
12. Flesch I.E.A., Kaufmann S.H.E. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone-marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:1991;3213-3219.
13. Flynn J.L., Goldstein M.M., Chan J., Triebold K.L., Pfeffer K., Loweinstein C.J., Schreiber R., Mak T.W., Bloom B.R. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:1995;561-572.
14. Flynn J.L., Goldstein M.M., Triebold K.L., Sypek J., Wolf S., Bloom B.R. Interleukin-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis. J. Immunol. 155:1995;2515-2524.
15. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglia cells. Eur. J. Immunol. 17:1987;1271-1278.
16. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
17. Giulian D., Baker T.J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6:1986;2163-2178.
18. Govoni G., Gros P. Macrophage Nramp1 and its role in resistance to microbial infections. Inflammation Res. 47:1998;277-284.
19. Govoni G., Vidal S., Gauthier S., Skamene E., Malo D., Gros P. The Bcg/Ity/Lsh locus-genetic transfer of resistance to infection in C57bl/6J mice transgenic for the Nramp1 (Gly 169) allele. Infect. Immun. 64:1996;2923-2929.
20. Gruenheid S., Cellier M., Vidal S., Gros P. Identification and characterization of a second mouse Nramp gene. Genomics. 25:1995;514-525.
21. Hopewell, P.C., 1994. Overview of clinical tuberculosis. In: Bloom, B.R. (Ed.), Tuberculosis: Pathogenesis, Protection and Control. ASM Press, Washington, DC, pp. 25-46.
22. Lissner C.R., Weinstein D.L., O'Brien A. Mouse chromosome 1 Ity locus regulates microbicidal activity of isolated peritoneal macrophages. J. Immunol. 135:1985;544-547.
23. Malo D., Vogan K., Vidal S., Hu J., Cellier M., Shurr E., Fucks A., Burnstead N., Morgan K., Gros P. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics. 23:1994;51-61.
24. Nathan C.F. Secretory products of macrophages. J. Clin. Invest. 79:1987;319-326.
25. Puliti M., Radzioch D., Mazzolla R., Barluzzi R., Bistoni F., Blasi E. Influence of the bcg locus on macrophage response to the dimorphic fungus Candida albicans. Infect. Immun. 63:1995;4170-4173.
26. Radzioch D., Hudson T., Boulè M., Barrera L., Urbance J.W., Varesio L., Skamene E. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone-marrow derived macrophage cell lines. J. Leukocyte Biol. 50:1991;263-272.
27. Radzioch D., Kramnik I., Skamene E. Molecular mechanisms of natural resistance to mycobacterial infections. Circ. Shock. 44:1995;115-120.
28. Raff M.C., Mirsky R., Fields K.L., Lisak R.P., Dorfman S.H., Silberger D.H., Gregson N.A., Liebowitz S., Kennedy M.C. Galactocerebroside in a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature. 274:1978;813-816.
29. r congenic mouse strain. Infect. Immun. 59:1991;3935-3942.
30. Skamene E. Inflammatory vs. protective host responses. The Bcg gene story. Immunobiology. 191:1994;451-460.
31. Stach J.L., Gros P., Forget A., Skamene E. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J. Immunol. 132:1984;888-892.
32. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 73:1993;469-485.
33. Vidal S., Tremblay M., Govoni G., Gauthier S., Sebastiani G., Malo D., Skamene E., Olivier M., Jothy S., Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp 1 gene. J. Exp. Med. 182:1995;655-666.